Nobel Hygiene files for IPO; plans Halol capacity and warehouse expansion

Quadria Capital-backed Nobel Hygiene has filed for an IPO with a fresh issue of up to ₹150 crore and an OFS of up to 1.55 crore shares. Proceeds are slated for debt repayment and expansion of Halol manufacturing, warehousing and adult-diaper capacity. The company reaches about 2.7 lakh retail outlets.

— Source published Fri, 21 Aug, 2026, 12:42 IST · First seen Fri, 21 Aug, 2026, 12:45 IST · Source Outlook Business

What happened

Nobel Hygiene filed for an IPO comprising a ₹150 crore fresh issue and 1.55 crore-share OFS. Funds will repay debt and expand Halol capacity, warehousing and

Key facts

  • Fresh issue up to ₹150 crore
  • OFS up to 1.55 crore equity shares
  • Over 1,150 SKUs as of March 31, 2026
  • 14 manufacturing lines
  • Annual capacity nearly 1,891 million units
  • Distribution across about 2.7 lakh retail outlets
  • Nearly 300 stockists
  • More than 400 distributors
  • Exports to 19 countries
  • FY2026 revenue ₹846.75 crore, up 14.6% from ₹739.14 crore
  • FY2026 profit ₹18.91 crore versus ₹2.28 crore

Why this matters

The IPO-funded capacity build signals Nobel Hygiene is positioning to scale in adult diapers and personal care, making it a more consequential competitor or partnership candidate in India’s hygiene market.

What to watch

  • IPO subscription levels, valuation versus listed FMCG and hygiene peers, and anchor investor participation.
  • Amount of debt repaid and resulting interest-cost reduction.
  • Halol expansion commissioning date, capacity additions and utilization ramp.
  • Adult-diaper revenue share, repeat purchase indicators and institutional customer wins.
  • Revenue growth sustaining above mid-teens without a material rise in advertising, trade spends or receivable days.
  • Gross-margin movement amid pulp, polymer, packaging and freight-cost volatility.
  • Finalize DRHP disclosures on brand mix, capacity utilization, debt reduction and use of proceeds.
  • Prioritize adult-diaper launches, institutional sales and pharmacy/hospital distribution where category penetration is underdeveloped.
  • Use warehouse expansion to improve fill rates in high-growth regions and lower freight costs.
  • Increase modern trade, e-commerce and quick-commerce visibility while protecting general-trade distributor economics.
  • Position IPO equity raise as a balance-sheet and capacity-led growth story rather than a pure promoter exit, given the OFS component.